Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
Asian Journal of Andrology · 2023-05 · 25 (3) · 356-360
DOI: 10.4103/aja202267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Andrology, online erschienen am 11.10.2022. Verfasst von Jing Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Transurethral Resection of Prostate, Enhanced Recovery After Surgery. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Enhanced recovery after surgery (ERAS) measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia (BPH). This study was performed on patients with BPH who required surgical intervention. From July 2019 to June 2020, the ERAS program was applied to 248 patients, and the conventional program was applied to 238 patients. After 1 year of follow-up, the differences between the ERAS group and the conventional group were evaluated. The ERAS group had a shorter time of urinary catheterization compared with the conventional group (mean ± standard deviation [s.d.]: 1.0 ± 0.4 days vs 2.7 ± 0.8 days, P < 0.01), and the pain (mean ± s.d.) was significantly reduced through postoperative hospitalization days (PODs) 0–2 (POD 0: 1.7 ± 0.8 vs 2.4 ± 1.0, P < 0.01; POD 1: 1.6 ± 0.9 vs 3.5 ± 1.3, P < 0.01; POD 2: 1.2 ± 0.7 vs 3.0 ± 1.3, P < 0.01). No statistically significant difference was found in the rate of postoperative complications, such as postoperative bleeding ( P = 0.79), urinary retention ( P = 0.40), fever ( P = 0.55), and readmission ( P = 0.71). The hospitalization cost of the ERAS group was similar to that of the conventional group (mean ± s.d.: 16 927.8 ± 5808.1 Chinese Yuan [CNY] vs 17 044.1 ± 5830.7 CNY, P =0.85). The International Prostate Symptom Scores (IPSS) and quality of life (QoL) scores in the two groups were also similar when compared at 1 month, 3 months, 6 months, and 12 months after discharge. The ERAS program we conducted was safe, repeatable, and efficient. In conclusion, patients undergoing the ERAS program experienced less postoperative stress than those undergoing the conventional program.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.
- West China School of Medicine, Sichuan University, Chengdu 610000, China.
Zitieren
APA
Zhou, J., Peng, Z. F., Song, P., Yang, L. C., Liu, Z. H., Shi, S. K., Wang, L. C., Chen, J. H., Liu, L. R., & Dong, Q. (2023). Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia. Asian Journal of Andrology, 25(3), 356-360. https://doi.org/10.4103/aja202267
Vancouver
Zhou J, Peng ZF, Song P, Yang LC, Liu ZH, Shi SK, et al. Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia. Asian Journal of Andrology. 2023;25(3):356-360. doi:10.4103/aja202267
BibTeX
@article{Zhou2023,
author = {Zhou, Jing and Peng, Zhu-Feng and Song, Pan and Yang, Lu-Chen and Liu, Zheng-Huan and Shi, Shuai-Ke and Wang, Lin-Chun and Chen, Jun-Hao and Liu, Liang-Ren and Dong, Qiang},
title = {Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia},
journal = {Asian Journal of Andrology},
year = {2023},
volume = {25},
number = {3},
pages = {356--360},
doi = {10.4103/aja202267}
}
EUVIMED